Risk factors for decreased bone mineral density in men with type 2 diabetes.

BACKGROUND: Type 2 diabetes and osteoporosis are widespread diseases in the middle-aged and elderly people. Most studies of osteoporosis in patients with type 2 diabetes have been performed in women; meantime risk factors for lowering bone mineral density (BMD) in men have been little studied.

AIMS: to identify risk factors for decreased BMD at the lumbar spine, femoral neck and forearm in men with type 2 diabetes.

METHODS: Eighty two men from 50 to 75 years old, with duration of diabetes for at least one year, were included in the study. Individuals with known risk factors for secondary osteoporosis were not included. Twenty-three men with normal BMD having no diabetes or obesity were acted as control. The T-score at the lumbar spine, femoral neck and forearm of a non-dominant arm, as well as body composition parameters, were evaluated by dual-energy X-ray absorptiometry. The levels of hormones that affect bone metabolism (parathyroid hormone, free testosterone, 25-OH vitamin D) were measured in blood serum by ELISA. Risk factors for reducing BMD were identified using multivariate regression analysis and receiver operating characteristic (ROC) curves.

RESULTS: Among patients with diabetes, 49 individuals had normal BMD and 33 showed decreased T-score values (<-1 SD). Free testosterone <5.92 pg/ml was predictor for decreased BMD at the lumbar spine (OR=4.4, p=0.04). For femoral neck, the risk factors were body weight <95.5 kg (OR=2.8, p=0.04), total fat mass <27 kg (OR=3.3, p=0.03), truncal fat mass<17.5 kg(OR=4.5, p=0.006), android (central abdominal) fat mass <3.2 kg(OR=4.0, p=0.01), gynoid (hip) fat mass <3.5 kg(OR=3.3, p=0.02), and lean mass <59 kg(OR=3.0, p=0.04). Risk factors for reduced BMD at the forearm were diabetes duration>15.5 years (OR=3.7, p=0.03) and HbA1c <8.15% (OR=3.8, p=0.03). Parathyroid hormone and 25-OH-vitamin D did not predict BMD independently.

CONCLUSIONS: In men with type 2 diabetes, low free testosterone is a risk factor for decreased BMD in the lumbar spine, and diabetes duration is a risk factor for decreased BMD in the forearm. The presence of obesity is associated with an increase in BMD in the femoral neck; a high HbA1c is associated with an increase in BMD in the forearm.

1. Dedov II, Shestakova MV, Vikulova OK, et al. Diabetes mellitus in Russian Federation: prevalence, morbidity, mortality, parameters of glycaemic control and structure of glucose lowering therapy according to the Federal Diabetes Register, status 2017. Diabetes mellitus. 2018;21(3):144-159. (In Russ.). https://doi.org/10.14341/DM9686

2. International Diabetes Federation [Internet]. Diabetes atlas. 9th ed., 2019. [cited 2020 Apr 09]. Available from: http://www.idf.org/diabetesatlas

3. Mkrtumyan AM. Osteoporosis as an underestimated complication of diabetes. Effective Рharmacotherapy. 2017;(9):51-54. (In Russ.).

4. Pisani P, Renna M, Conversano F, et al. Major osteoporotic fragility fractures: Risk factor updates and societal impact. World J Orthop. 2016;7(3):171-181. https://doi.org/10.5312/wjo.v7.i3.171

5. Lesnyak OM, Baranova IA, Belova KY, et al. Osteoporosis in the Russian Federation: epidemiology, medical, social and economic aspects of the problem. Traumatology and orthopedics of Russia. 2018;24(1):155-168 (In. Russ.). https://doi.org/10.21823/2311-2905-2018-24-1-155-168

6. Yalochkina TO, Belaya ZE, Rozhnskaya LY, et al. Bone fractures in patients with type 2 diabetes mellitus: Prevalence and risk factors. Diabetes mellitus. 2016;19(5):359-365. (In Russ.). https://doi.org/10.14341/DM7796

7. Center JR, Nguyen TV, Schneider D Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999;353(9156):878-82. https://doi.org/10.1016/S0140-6736(98)09075-8

8. Dedov II, Shestakova MV, Mayorov AY, et al. Standards of specialized diabetes care. 8th ed. Diabetes mellitus. 2017;20(1S):1-121. (In Russ.). https://doi.org/10.14341/DM20171S8

9. Koichubekov BK, Sorokina MA, Mkhitaryan XE. Sample size determination in planning of scientific research. International Journal of Applied and Fundamental Research. 2014;(4):71-74. (In Russ.).

10. Melnichenko GA, Shestakova MV, Rozhivanov RV. The clinical and epidemiological characteristics of hypogonadism in men with type 2 diabetes mellitus. Diabetes Mellitus. 2019;22(6):536-541. (In Russ.). https://doi.org/10.14341/DM10211

11. Khosla S, Monroe DG. Regulation of Bone Metabolism by Sex Steroids. Cold Spring Harb Perspect Med. 2018;8(1):a031211. https://doi.org/11.1101/cshperspect.a031211

12. Mohamad NV, Soelaiman IN, Chin KY. A concise review of testosterone and bone health. Clin Interv Aging. 2016;11:1317-1324. https://doi.org/10.2147/CIA.S115472

13. Narla RR, Ott SM Bones and the sex hormones. Kidney Int. 2018;94(2):239-242. https://doi.org/ 10.1016/j.kint.2018.03.021

14. Fillo J, Levcikova M, Luha J, et al. The effect of long term testosterone replacement therapy on bone mineral density. Bratisl Lek Listy. 2019;120(4):291-294. https://doi.org/10.4149/BLL_2019_039

15. Scott D, Seibel MJ, Cumming R, et al. Associations of Body Composition Trajectories with Bone Mineral Density, Muscle Function, Falls and Fractures in Older Men: The Concord Health and Ageing in Men Project. J Gerontol A Biol Sci Med Sci. 2019;75(5):939-945. https://doi.org/10.1093/gerona/glz184

16. Klimontov VV, Fazullina ON. The relationship of total body composition with bone mineral density in postmenopausal women with type 2 diabetes. Diabetes mellitus. 2015;18(1):65-69. (In Russ.). https://doi.org/10.14341/DM2015165-69

17. Gonnelli S, Caffarelli C, Nuti R. Obesity and fracture risk. Clin Cases Miner Bone Metab. 2014;11(1):9-14. https://doi.org/10.11138/ccmbm/2014.11.1.009

18. Kim SH, Yi SW, Yi JJ, et al. Association Between Body Mass Indexand the Risk of Hip Fracture by Sex and Age: A Prospective Cohort Study. J Bone Miner Res. 2018;33(9):1603-1611. https://doi.org/10.1002/jbmr.3464

19. Martinez–Laguna D., Tebe C., Javaid M. Incident type 2 diabetes and hip fracture risk: a population–based matched cohort study. Osteoporos Int. 2015;26(2):827-833. https://doi.org/10.1007/s00198-014-2986-9.

20. Rathmann W, Kostev K. Fracture risk in patients with newly diagnosed type 2 diabetes: a retrospective database analysis in primary care. J Diabetes Complications. 2015;29(6):766-770. https://doi.org/10.1016/j.jdiacomp.2015.05.007

21. Aguirre LE, Colleluori G, Dorin R, et al. Hypogonadal Men with Higher Body Mass Index have Higher Bone Density and Better Bone Quality but Reduced Muscle Density. Calcif Tissue Int. 2017;101(6):602-611. https://doi.org/10.1007/s00223-017-0316-x

22. Kirk B, Zanker J, Duque G. Osteosarcopenia: epidemiology, diagnosis, and treatment-facts and numbers. J Cachexia Sarcopenia Muscle. 2020;11(3):609-618. https://doi.org/10.1002/jcsm.12567

23. Junjie W, Dongsheng H, Lei S, et al. Testosterone Replacement Therapy Has Limited Effect on Increasing Bone Mass Density in Older Men: a Meta-analysis. Curr Pharm Des. 2019;25(1):73-84. https://doi.org/10.2174/1381612825666190206223244

24. Corona G, Vignozzi L, Sforza A, et al. Obesity and late-onset hypogonadism. Mol Cell Endocrinol. 2015;418(2):120-33. https://doi.org/10.1016/j.mce.2015.06.031

25. Jang M, Kim H, Lea S, et al. Effect of duration of diabetes on bone mineral density: a population study on East Asian males. BMC Endocr Disord. 2018;18(1):61. https://doi.org/10.1186/s12902-018-0290-y

26. Valderrбbano RJ, Linares MI. Diabetes mellitus and bone health: epidemiology, etiology and implications for fracture risk stratification. Clin Diabetes Endocrinol. 2018;4:9. https://doi.org/10.1186/s40842-018-0060-9

27. Oei L, Zillikens M, Dehghan A, et al. High Bone Mineral Density and Fracture Risk in Type 2 Diabetes as Skeletal Complications of Inadequate Glucose Control: The Rotterdam Study. Diabetes Care. 2013; 36(6):1619-1628 https://doi.org/10.2337/dc12-1188

28. Murray CE, Coleman CM. Impact of Diabetes Mellitus on Bone Health. Int J Mol Sci. 2019;20(19):4873. https://doi.org/10.3390/ijms20194873

29. Baqiyyah N, Conway P, Long D, et al. Glycemic Control and Fracture Risk in Elderly Patients with Diabetes. Diabetes Res Clin Pract. 2016;115:47-53. https://doi.org/10.1016/j.diabres.2016.03.009

30. Li CI, Liu CS, Lin WY, et al. Glycated Hemoglobin Level and Risk of Hip Fracture in Older People with Type 2 Diabetes: A Competing Risk Analysis of Taiwan Diabetes Cohort Study. J Bone Miner Res. 2015;30(7):1338-46. https://doi.org/10.1002/jbmr.2462